BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Flasar MH, Johnson T, Roghmann M, Cross RK. Disparities in the use of immunomodulators and biologics for the treatment of inflammatory bowel disease: A retrospective cohort study: . Inflammatory Bowel Diseases 2008;14:13-9. [DOI: 10.1002/ibd.20298] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Flasar M, Patil S. Radiating disparity in IBD. Dig Dis Sci. 2014;59:504-506. [PMID: 24318801 DOI: 10.1007/s10620-013-2922-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
2 Lin KK, Sewell JL. The effects of race and socioeconomic status on immunomodulator and anti-tumor necrosis factor use among ambulatory patients with inflammatory bowel disease in the United States. Am J Gastroenterol 2013;108:1824-30. [PMID: 24300857 DOI: 10.1038/ajg.2013.192] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
3 Hou JK, El-Serag H, Thirumurthi S. Distribution and manifestations of inflammatory bowel disease in Asians, Hispanics, and African Americans: a systematic review. Am J Gastroenterol. 2009;104:2100-2109. [PMID: 19471256 DOI: 10.1038/ajg.2009.190] [Cited by in Crossref: 124] [Cited by in F6Publishing: 123] [Article Influence: 9.5] [Reference Citation Analysis]
4 Park MD, Bhattacharya J, Park K. Differences in healthcare expenditures for inflammatory bowel disease by insurance status, income, and clinical care setting. PeerJ 2014;2:e587. [PMID: 25279267 DOI: 10.7717/peerj.587] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
5 Abbas AM, Almukhtar RM, Loftus EV, Lichtenstein GR, Khan N. Risk of melanoma and non-melanoma skin cancer in ulcerative colitis patients treated with thiopurines: a nationwide retrospective cohort. Am J Gastroenterol. 2014;109:1781-1793. [PMID: 25244964 DOI: 10.1038/ajg.2014.298] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 6.1] [Reference Citation Analysis]
6 Barnes EL, Kochar B, Long MD, Martin CF, Kappelman MD. Minority Pediatric Patients with Inflammatory Bowel Disease Demonstrate an Increased Length of Stay. Inflamm Bowel Dis 2017;23:2189-96. [PMID: 29140942 DOI: 10.1097/MIB.0000000000001267] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
7 Sewell JL, Inadomi JM, Yee HF. Race and inflammatory bowel disease in an urban healthcare system. Dig Dis Sci. 2010;55:3479-3487. [PMID: 20936350 DOI: 10.1007/s10620-010-1442-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
8 Szigethy EM, Allen JI, Reiss M, Cohen W, Perera LP, Brillstein L, Cross RK, Schwartz DA, Kosinski LR, Colton JB, LaRusso E, Atreja A, Regueiro MD. White Paper AGA: The Impact of Mental and Psychosocial Factors on the Care of Patients With Inflammatory Bowel Disease. Clin Gastroenterol Hepatol 2017;15:986-97. [PMID: 28300693 DOI: 10.1016/j.cgh.2017.02.037] [Cited by in Crossref: 50] [Cited by in F6Publishing: 42] [Article Influence: 10.0] [Reference Citation Analysis]
9 Farrukh A, Mayberry J. Apparent Disparities in Hospital Admission and Biologic Use in the Management of Inflammatory Bowel Disease between 2014–2018 in Some Black and Ethnic Minority (BEM) Populations in England. GastrointestDisord 2020;2:144-51. [DOI: 10.3390/gidisord2020015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
10 Griglione N, Yarandi S, Srinivasan J, Ahearn T, Dhere T. A comparison of abdominal surgical outcomes between African-American and Caucasian Crohn's patients. Int J Colorectal Dis 2014;29:917-22. [PMID: 24828990 DOI: 10.1007/s00384-014-1902-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
11 Li D, Collins B, Velayos FS, Liu L, Lewis JD, Allison JE, Flowers NT, Hutfless S, Abramson O, Herrinton LJ. Racial and ethnic differences in health care utilization and outcomes among ulcerative colitis patients in an integrated health-care organization. Dig Dis Sci 2014;59:287-94. [PMID: 24173809 DOI: 10.1007/s10620-013-2908-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
12 Farrukh A, Mayberry J. Evidence of Differences and Discrimination in the Delivery of Care: Colorectal Screening in Healthy People and in the Care and Surveillance of Patients with Inflammatory Bowel Disease. GastrointestDisord 2019;1:253-60. [DOI: 10.3390/gidisord1020020] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Afzali A, Cross RK. Racial and Ethnic Minorities with Inflammatory Bowel Disease in the United States: A Systematic Review of Disease Characteristics and Differences. Inflamm Bowel Dis 2016;22:2023-40. [PMID: 27379446 DOI: 10.1097/MIB.0000000000000835] [Cited by in Crossref: 40] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
14 Dotson JL, Kappelman MD, Chisolm DJ, Crandall WV. Racial disparities in readmission, complications, and procedures in children with Crohn's disease. Inflamm Bowel Dis 2015;21:801-8. [PMID: 25742396 DOI: 10.1097/MIB.0000000000000325] [Cited by in Crossref: 30] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
15 Flasar MH, Chao J, Ozbay AB, Skup M, Lu M, Cross R. Biological and Immunomodulator Use in Crohnʼs Disease in a Medicaid Population: . Inflammatory Bowel Diseases 2016;22:1056-64. [DOI: 10.1097/mib.0000000000000730] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Huang JS, Tobin A, Harvey L, Nelson TR. Diagnostic medical radiation in pediatric patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2011;53:502-506. [PMID: 22020539 DOI: 10.1097/mpg.0b013e31820d5d84] [Cited by in Crossref: 29] [Cited by in F6Publishing: 4] [Article Influence: 2.9] [Reference Citation Analysis]
17 Dotson JL, Cho M, Bricker J, Kappelman MD, Chisolm DJ, Tomer G, Crandall WV. Race Differences in Initial Presentation, Early Treatment, and 1-year Outcomes of Pediatric Crohnʼs Disease: Results from the ImproveCareNow Network. Inflammatory Bowel Diseases 2017;23:767-74. [DOI: 10.1097/mib.0000000000001046] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
18 Arsoniadis EG, Ho YY, Melton GB, Madoff RD, Le C, Kwaan MR. African Americans and Short-Term Outcomes after Surgery for Crohn's Disease: An ACS-NSQIP Analysis. J Crohns Colitis 2017;11:468-73. [PMID: 27683803 DOI: 10.1093/ecco-jcc/jjw175] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
19 Sewell JL, Velayos FS. Systematic review: The role of race and socioeconomic factors on IBD healthcare delivery and effectiveness. Inflamm Bowel Dis. 2013;19:627-643. [PMID: 22623078 DOI: 10.1002/ibd.22986] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 6.4] [Reference Citation Analysis]
20 Asotibe JC, Akuna E, Williams D, Busari OA, Edigin E, Achebe I, Asotibe BM, Trick W, Mishra S. Racial differences in the outcomes of IBD hospitalizations: a national population-based study. Int J Colorectal Dis 2021. [PMID: 34694440 DOI: 10.1007/s00384-021-04052-z] [Reference Citation Analysis]
21 Nguyen GC, LaVeist TA, Harris ML, Wang MH, Datta LW, Brant SR. Racial disparities in utilization of specialist care and medications in inflammatory bowel disease. Am J Gastroenterol 2010;105:2202-8. [PMID: 20485281 DOI: 10.1038/ajg.2010.202] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 4.3] [Reference Citation Analysis]
22 Prideaux L, Kamm MA, De Cruz PP, Chan FK, Ng SC. Inflammatory bowel disease in Asia: a systematic review. J Gastroenterol Hepatol 2012;27:1266-80. [PMID: 22497584 DOI: 10.1111/j.1440-1746.2012.07150.x] [Cited by in Crossref: 195] [Cited by in F6Publishing: 196] [Article Influence: 19.5] [Reference Citation Analysis]
23 Barnes EL, Kochar B, Long MD, Pekow J, Ananthakrishnan A, Anyane-Yeboa A, Martin C, Galanko J, Herfarth HH, Kappelman MD, Sandler RS. Lack of Difference in Treatment Patterns and Clinical Outcomes Between Black and White Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis 2018;24:2634-40. [PMID: 29788063 DOI: 10.1093/ibd/izy179] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
24 Long MD, Herfarth HH, Pipkin CA, Porter CQ, Sandler RS, Kappelman MD. Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2010;8:268-274. [PMID: 20005977 DOI: 10.1016/j.cgh.2009.11.024] [Cited by in Crossref: 189] [Cited by in F6Publishing: 175] [Article Influence: 15.8] [Reference Citation Analysis]
25 Kandavel P, Eder SJ, Adler J; ImproveCareNow Network Pediatric IBD Learning Health System. Reduced Systemic Corticosteroid Use among Pediatric Patients With Inflammatory Bowel Disease in a Large Learning Health System. J Pediatr Gastroenterol Nutr 2021;73:345-51. [PMID: 34415262 DOI: 10.1097/MPG.0000000000003182] [Reference Citation Analysis]
26 Daperno M, Sostegni R, Canaparo R, Serpe L, Lavagna A, Crocellà L, Castagno F, Vernetto A, Rigazio C, Ercole E. Prospective study of the effects of concomitant medications on thiopurine metabolism in inflammatory bowel disease. Aliment Pharmacol Ther. 2009;30:843-853. [PMID: 19650826 DOI: 10.1111/j.1365-2036.2009.04106.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
27 Farrukh A, Mayberry J. Apparent discrimination in the provision of biologic therapy to patients with Crohn's disease according to ethnicity. Public Health 2015;129:460-4. [DOI: 10.1016/j.puhe.2015.01.029] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
28 Long MD, Martin CF, Pipkin CA, Herfarth HH, Sandler RS, Kappelman MD. Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease. Gastroenterology. 2012;143:390-399.e1. [PMID: 22584081 DOI: 10.1053/j.gastro.2012.05.004] [Cited by in Crossref: 284] [Cited by in F6Publishing: 248] [Article Influence: 28.4] [Reference Citation Analysis]
29 Ghazi LJ, Lydecker AD, Patil SA, Rustgi A, Cross RK, Flasar MH. Racial differences in disease activity and quality of life in patients with Crohn's disease. Dig Dis Sci 2014;59:2508-13. [PMID: 24718861 DOI: 10.1007/s10620-014-3141-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
30 Farrukh A, Mayberry JF. Ethnic variations in the provision of biologic therapy for Crohn's disease: a Freedom of Information study. Med Leg J 2015;83:104-8. [DOI: 10.1177/0025817214563907] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
31 Patil SA, Flasar MH, Lin J, Lingohr-Smith M, Skup M, Wang S, Chao J, Cross RK. Reduced Imaging Radiation Exposure and Costs Associated with Anti-Tumor Necrosis Factor Therapy in Crohn's Disease. Dig Dis Sci 2019;64:60-7. [PMID: 30311154 DOI: 10.1007/s10620-018-5322-y] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
32 Long MD, Martin C, Sandler RS, Kappelman MD. Increased risk of herpes zoster among 108 604 patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2013;37:420-429. [PMID: 23240738 DOI: 10.1111/apt.12182] [Cited by in Crossref: 96] [Cited by in F6Publishing: 89] [Article Influence: 9.6] [Reference Citation Analysis]
33 Malaty HM, Sansgiry S, Artinyan A, Hou JK. Time Trends, Clinical Characteristics, and Risk Factors of Chronic Anal Fissure Among a National Cohort of Patients with Inflammatory Bowel Disease. Dig Dis Sci 2016;61:861-4. [PMID: 26514675 DOI: 10.1007/s10620-015-3930-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
34 Moore L, Gaffney K, Lopez R, Shen B. Comparison of the natural history of ulcerative colitis in African Americans and non-Hispanic Caucasians: a historical cohort study. Inflamm Bowel Dis. 2012;18:743-749. [PMID: 21688351 DOI: 10.1002/ibd.21796] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
35 Proksell SS, Greer JB, Theisen BK, Davis PL, Rosh JR, Keljo DJ, Goyal A, Shah SA, Brand MH, Herfarth HH, Cross RK, Siegel CA, Koltun WA, Isaacs KL, Regueiro MD. IBD LIVE Case Series: Case 9: Do Race and Extraintestinal Manifestations Affect Treatment of Severe Crohn's Colitis? Inflamm Bowel Dis 2018;24:698-713. [PMID: 29562279 DOI: 10.1093/ibd/izx114] [Reference Citation Analysis]